Courtney Finlayson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Courtney Finlayson has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Diane Chen
Ann & Robert H. Lurie Children’s Hospital of Chicago
11 shared publications - Emilie K. Johnson
Division of Urology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, USA
9 shared publications - Jaclyn Lennon Papadakis
Pritzker Department of Psychiatry and Behavioral Health, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, USA
6 shared publications - Allison Goetsch Weisman
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
5 shared publications Emilie K. Johnson
Division of Urology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
5 shared publicationsIlina Rosoklija
5 shared publications
Latest Publications
- Open Access
- 16 July 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (6) , 1619-1629
Decision-making experiences in gonadectomy and gonadal tissue cryopreservation for adolescents/young adults and parents of individuals with differences of sex development: A qualitative study
- 16 July 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (6) , 1619-1629
Open AccessDecision-making experiences in gonadectomy and gonadal tissue cryopreservation for adolescents/young adults and parents of individuals with differences of sex development: A qualitative study
- Open Access
- 8 July 2025
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 9 (9) , bvaf112
Perspectives From Adolescents and Young Adults With Klinefelter Syndrome on Testosterone Supplementation and Fertility
Context: Infertility and testicular dysfunction are typical features of Klinefelter syndrome (KS; 47,XXY). KS affects ∼1:600 male births, making it the most common chromosomal aneuploidy. As more adolescent and young adult (AYA) patients with KS seek care, it becomes increasingly important to investigate their understanding of information about testosterone supplementation and infertility. Objective: This qualitative study aimed to explore the perspectives of AYA with KS about testicular dysfunction, specifically the likely need for testosterone replacement and, if desired, fertility-related interventions. Methods: Semistructured interviews were conducted with 13 AYA with KS ages 14 to 23 years (mean, age 16 years). Reflexive thematic analysis was applied. Results: Two themes were generated concerning testicular dysfunction: understanding of testosterone supplementation and fertility discussions. Most individuals lacked a comprehensive understanding of the use and health benefits of testosterone treatment. A facilitator to testosterone replacement adherence was perceived health benefits, whereas a barrier was the mode of delivery. All participants had either seen a fertility specialist or planned to see one. Emotional responses to infertility varied; however, many had negative reactions and emphasized the importance of learning that there are many ways to have children. Conclusion: This study improves the understanding of AYA with KS perspectives regarding testosterone supplementation and infertility, which in turn may help providers implement effective clinical and educational interventions for this growing patient population.
- 8 July 2025
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 9 (9) , bvaf112
Open AccessPerspectives From Adolescents and Young Adults With Klinefelter Syndrome on Testosterone Supplementation and Fertility
Context: Infertility and testicular dysfunction are typical features of Klinefelter syndrome (KS; 47,XXY). KS affects ∼1:600 male births, making it the most common chromosomal aneuploidy. As more adolescent and young adult (AYA) patients with KS seek care, it becomes increasingly important to investigate their understanding of information about testosterone supplementation and infertility. Objective: This qualitative study aimed to explore the perspectives of AYA with KS about testicular dysfunction, specifically the likely need for testosterone replacement and, if desired, fertility-related interventions. Methods: Semistructured interviews were conducted with 13 AYA with KS ages 14 to 23 years (mean, age 16 years). Reflexive thematic analysis was applied. Results: Two themes were generated concerning testicular dysfunction: understanding of testosterone supplementation and fertility discussions. Most individuals lacked a comprehensive understanding of the use and health benefits of testosterone treatment. A facilitator to testosterone replacement adherence was perceived health benefits, whereas a barrier was the mode of delivery. All participants had either seen a fertility specialist or planned to see one. Emotional responses to infertility varied; however, many had negative reactions and emphasized the importance of learning that there are many ways to have children. Conclusion: This study improves the understanding of AYA with KS perspectives regarding testosterone supplementation and infertility, which in turn may help providers implement effective clinical and educational interventions for this growing patient population.
- Open Access
- 24 June 2025
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (3) , e70074
Finding acceptance: How adolescents and young adults with Klinefelter Syndrome navigate identity, disclosure, and support
Klinefelter syndrome (KS; 47, XXY) is the most common chromosomal aneuploidy, affecting ~1:600 male births. Due to recent technological advances, KS is diagnosed more often in young individuals. This emerging population of adolescent and young adult (AYA) patients with KS seeking care makes it increasingly important to understand the unique experiences and perspectives of these individuals. This qualitative study explored (1) the psychosocial well‐being of AYA with KS and (2) resources and support systems AYA with KS utilize to cope with challenges related to their diagnosis. This study included 13 participants ages 14–23 (M age 16 years) who completed semi‐structured individual interviews. Reflexive thematic analysis was used. Three themes were generated concerning psychosocial well‐being, resources, and support systems of AYA with KS: (1) “I'm a little different”—Rejecting stigmatization and integrating a diagnosis of KS into one's identity, (2) “Let it out”—Lessons learned when disclosing one's diagnosis of KS to others, and (3) “They accept me for who I am”—The building blocks of a support system. Participants largely viewed KS as part of themselves but not their whole identity and expressed not wanting to be labeled by others as “disabled.” Participants voiced that disclosing KS to trusted others often provides a sense of relief, and that it is important to have a varied support system that includes individuals like parents, friends, and romantic partners. This study improves the understanding of what support resources AYA with KS are using, or not using, and provides insights into their psychosocial well‐being, which in turn may help providers implement effective clinical interventions and promote better psychosocial outcomes for this growing patient population.
- 24 June 2025
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (3) , e70074
Open AccessFinding acceptance: How adolescents and young adults with Klinefelter Syndrome navigate identity, disclosure, and support
Klinefelter syndrome (KS; 47, XXY) is the most common chromosomal aneuploidy, affecting ~1:600 male births. Due to recent technological advances, KS is diagnosed more often in young individuals. This emerging population of adolescent and young adult (AYA) patients with KS seeking care makes it increasingly important to understand the unique experiences and perspectives of these individuals. This qualitative study explored (1) the psychosocial well‐being of AYA with KS and (2) resources and support systems AYA with KS utilize to cope with challenges related to their diagnosis. This study included 13 participants ages 14–23 (M age 16 years) who completed semi‐structured individual interviews. Reflexive thematic analysis was used. Three themes were generated concerning psychosocial well‐being, resources, and support systems of AYA with KS: (1) “I'm a little different”—Rejecting stigmatization and integrating a diagnosis of KS into one's identity, (2) “Let it out”—Lessons learned when disclosing one's diagnosis of KS to others, and (3) “They accept me for who I am”—The building blocks of a support system. Participants largely viewed KS as part of themselves but not their whole identity and expressed not wanting to be labeled by others as “disabled.” Participants voiced that disclosing KS to trusted others often provides a sense of relief, and that it is important to have a varied support system that includes individuals like parents, friends, and romantic partners. This study improves the understanding of what support resources AYA with KS are using, or not using, and provides insights into their psychosocial well‐being, which in turn may help providers implement effective clinical interventions and promote better psychosocial outcomes for this growing patient population.
- Open Access
- 7 June 2025
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 39 (4) , 102017
Fertility in differences of sex development patients
- 7 June 2025
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 39 (4) , 102017
Open AccessFertility in differences of sex development patients
- 26 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (5) , 1146-1153
Role of endocrine and genetic evaluation for infants with proximal hypospadias
- 26 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (5) , 1146-1153
Role of endocrine and genetic evaluation for infants with proximal hypospadias
- Open Access
Long-read sequencing resolves the clinically relevant CYP21A2 locus, supporting a new clinical test for Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia (CAH), one of the most common inherited disorders, is caused by defects in adrenal steroidogenesis. It is potentially lethal if untreated and is associated with multiple comorbidities, including fertility issues, obesity, insulin resistance, and dyslipidemia. CAH can result from variants in multiple genes, but the most frequent cause is deletions and conversions in the segmentally duplicated RCCX module, which contains the CYP21A2 gene and a pseudogene. The molecular genetic test to identify pathogenic alleles is cumbersome, incomplete, and available from a limited number of laboratories. It requires testing parents for accurate interpretation, leading to healthcare inequity. Less severe forms are frequently misdiagnosed, and phenotype/genotype correlations incompletely understood. We explored whether emerging technologies could be leveraged to identify all pathogenic alleles of CAH, including phasing in proband-only cases. We targeted long-read sequencing outputs that would be practical in a clinical laboratory setting. Both HiFi-based and nanopore-based whole-genome long-read sequencing datasets could be mined to accurately identify pathogenic single-nucleotide variants, full gene deletions, fusions creating non-functional hybrids between the gene and pseudogene (“30-kb deletion”), as well as count the number of RCCX modules and phase the resulting multimodular haplotypes. On the Hi-Fi data set of 6 samples, the PacBio Paraphase tool was able to distinguish nine different mono-, bi-, and tri-modular haplotypes, as well as the 30-kb and whole gene deletions. To do the same on the ONT-Nanopore dataset, we designed a tool, Parakit, which creates an enriched local pangenome to represent known haplotype assemblies and map ClinVar pathogenic variants and fusions onto them. With few labels in the region, optical genome mapping was not able to reliably resolve module counts or fusions, although designing a tool to mine the dataset specifically for this region may allow doing so in the future. Both sequencing techniques yielded congruent results, matching clinically identified variants, and offered additional information above the clinical test, including phasing, count of RCCX modules, and status of the other module genes, all of which may be of clinical relevance. Thus long-read sequencing could be used to identify variants causing multiple forms of CAH in a single test.
Open AccessLong-read sequencing resolves the clinically relevant CYP21A2 locus, supporting a new clinical test for Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia (CAH), one of the most common inherited disorders, is caused by defects in adrenal steroidogenesis. It is potentially lethal if untreated and is associated with multiple comorbidities, including fertility issues, obesity, insulin resistance, and dyslipidemia. CAH can result from variants in multiple genes, but the most frequent cause is deletions and conversions in the segmentally duplicated RCCX module, which contains the CYP21A2 gene and a pseudogene. The molecular genetic test to identify pathogenic alleles is cumbersome, incomplete, and available from a limited number of laboratories. It requires testing parents for accurate interpretation, leading to healthcare inequity. Less severe forms are frequently misdiagnosed, and phenotype/genotype correlations incompletely understood. We explored whether emerging technologies could be leveraged to identify all pathogenic alleles of CAH, including phasing in proband-only cases. We targeted long-read sequencing outputs that would be practical in a clinical laboratory setting. Both HiFi-based and nanopore-based whole-genome long-read sequencing datasets could be mined to accurately identify pathogenic single-nucleotide variants, full gene deletions, fusions creating non-functional hybrids between the gene and pseudogene (“30-kb deletion”), as well as count the number of RCCX modules and phase the resulting multimodular haplotypes. On the Hi-Fi data set of 6 samples, the PacBio Paraphase tool was able to distinguish nine different mono-, bi-, and tri-modular haplotypes, as well as the 30-kb and whole gene deletions. To do the same on the ONT-Nanopore dataset, we designed a tool, Parakit, which creates an enriched local pangenome to represent known haplotype assemblies and map ClinVar pathogenic variants and fusions onto them. With few labels in the region, optical genome mapping was not able to reliably resolve module counts or fusions, although designing a tool to mine the dataset specifically for this region may allow doing so in the future. Both sequencing techniques yielded congruent results, matching clinically identified variants, and offered additional information above the clinical test, including phasing, count of RCCX modules, and status of the other module genes, all of which may be of clinical relevance. Thus long-read sequencing could be used to identify variants causing multiple forms of CAH in a single test.
- 1 November 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (5) , 660-671
Mixed Gonadal Dysgenesis: A Narrative Literature Review and Clinical Primer for the Urologist
Purpose:Mixed gonadal dysgenesis is a difference of sex development that is often confused with other conditions. Individuals have a 45,X/46,XY karyotype. Gonads are characterized by a streak gonad...
- 1 November 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (5) , 660-671
Mixed Gonadal Dysgenesis: A Narrative Literature Review and Clinical Primer for the Urologist
Purpose:Mixed gonadal dysgenesis is a difference of sex development that is often confused with other conditions. Individuals have a 45,X/46,XY karyotype. Gonads are characterized by a streak gonad...